• The Financial District

J&J IN TALKS WITH JAPAN, GATES FOUNDATION ON COVID-19 VACCINE DEALS

Johnson & Johnson is in talks with the government of Japan and the Bill and Melinda Gates Foundation about locking up allocations of its potential COVID-19 vaccine in advance of it producing any of the medicines, the company’s Chief Financial Officer Joseph Wolk told Reuters in an interview late on July 18, 2020.

It has already agreed to prioritize an allocation to the United States as part of its funding agreement with US government’s Biomedical Advanced Research and Development Authority (BARDA), Wolk told Carl O'Donnell and Manas Mishrahe of Reuters.


The Bill and Melinda Gates Foundation would focus on allocating any vaccine it acquired to developing countries, Wolk added. Reuters previously reported that J&J is also in talks with the European Union (EU.) “Nothing has been finalized yet. We continue to have those discussions,” Wolk told Reuters. “People from the countries and the organizations we mentioned want to lock in a certain minimum level of capacity that they would get.”


Wolk said that the “general construct” of the discussions is likely to take a form similar to AstraZeneca Plc’s deal with the US government, which provided $1.2 billion in drug development aid to the UK drugmaker in exchange for locking in a delivery of around 300 million doses for fall 2020. AstraZeneca has also signed a contract with France, Germany, Italy and the Netherlands for up to 400 million doses of its potential vaccine.


Register for Newsletter

  • LinkedIn
  • Instagram
  • YouTube

WHERE BUSINESS CLICKS

@2020 by The Financial District